Related by context. All words. (Click for frequent words.) 73 leukemia AML 73 recurrent glioblastoma multiforme 73 unresectable stage 72 CYT# potent vascular disrupting 71 metastatic malignant 71 alvespimycin 70 TTF Therapy 70 Glioblastoma Multiforme GBM 70 metastatic bladder 70 biliary tract cancer 70 metastatic malignant melanoma 70 recurrent glioblastoma multiforme GBM 70 metastatic gastric 70 HuMax EGFr 69 recurrent NSCLC 69 Gleevec resistant 69 unresectable tumors 69 metastatic renal cell carcinoma 69 refractory metastatic 69 relapsed MM 69 metastatic colorectal carcinoma 69 erlotinib Tarceva ® 69 LHRH receptor positive 69 recurrent malignant glioma 69 cilengitide 69 colorectal liver metastases 69 anti angiogenic therapy 69 multiple myeloma MM 69 relapsed refractory multiple myeloma 69 forodesine 69 Myelodysplastic Syndrome MDS 69 ACTEMRA TM 69 cisplatin chemotherapy 69 liver metastasis 69 receptor tyrosine kinase inhibitor 69 metastatic GIST 68 Aflibercept 68 glioblastoma multiforme GBM 68 non metastatic osteosarcoma 68 basal cell carcinoma BCC 68 cediranib 68 peritoneal carcinomatosis 68 hepatocellular cancer 68 relapsed multiple myeloma 68 leukemia CLL 68 refractory CTCL 68 pancreatic NET 68 FOLFOX6 68 heavily pretreated 68 Glioblastoma Multiforme 68 relapsed ovarian cancer 68 ara C 68 prostate cancer HRPC 68 dasatinib Sprycel 68 gastrointestinal stromal tumors GIST 68 antibody MAb 68 Hepatocellular Carcinoma HCC 68 leukemia ALL 68 gemcitabine Gemzar ® 68 HBeAg negative 67 pancreatic adenocarcinoma 67 metastatic hormone refractory 67 squamous cell carcinoma SCC 67 systemic ALCL 67 gastrointestinal stromal tumor GIST 67 lumiliximab 67 refractory Hodgkin 67 thalidomide Thalomid 67 tumors GIST 67 stage IIIB 67 invasive candidiasis 67 visilizumab 67 antiangiogenic therapy 67 refractory CLL 67 colorectal cancer liver metastases 67 gefitinib Iressa 67 Pemetrexed 67 GRN# 67 relapsing remitting MS RRMS 67 haematological cancers 67 CHOP chemotherapy 67 metastatic neuroendocrine tumors 67 docetaxel Taxotere ® 67 relapsing multiple sclerosis 67 indolent NHL 67 chronic granulomatous disease 67 gastric adenocarcinoma 67 Proxinium TM 67 refractory NSCLC 67 fistulizing Crohn disease 67 prostate cancer CRPC 67 axitinib 67 HER2 positive metastatic breast 67 riociguat 67 anti angiogenic agents 67 assessing T DM1 67 VELCADE melphalan 67 neovascular diseases 67 metaglidasen 67 cetuximab Erbitux ® 67 oral prodrug 67 refractory chronic lymphocytic 67 BRIM2 67 fallopian tube carcinoma 67 mRCC 66 Ophena TM 66 oral ridaforolimus 66 CTAP# Capsules 66 Golimumab 66 estramustine 66 CBLC# 66 vidofludimus 66 catheter occlusion 66 rituximab refractory 66 Aplidin 66 ZACTIMA 66 relapsed ALL 66 imatinib Gleevec ® 66 IV NSCLC 66 stage IIIB IV 66 PAOD 66 CIMZIA TM certolizumab pegol 66 EGFR mutation positive 66 CIMZIA ™ 66 cisplatin gemcitabine 66 enzastaurin 66 Mitomycin C 66 lupus nephritis 66 kidney urologic 66 evaluating tivozanib 66 metastatic castration resistant 66 Chronic lymphocytic leukemia 66 relapsing MS 66 metastatic colorectal 66 cell lymphoma CTCL 66 immunomodulatory therapy 66 commercialize deforolimus 66 carcinoid tumors 66 Ceflatonin 66 pediatric malignancies 66 relapsed refractory AML 66 Sezary syndrome 66 castration resistant prostate cancer 66 phase IIb clinical 66 metastatic pancreatic 66 refractory anaplastic astrocytoma 66 bortezomib Velcade 66 concurrent chemoradiation 66 castrate resistant prostate cancer 66 FOLFOX chemotherapy 66 irinotecan chemotherapy 66 de novo kidney transplant 66 Xanafide 66 overactive bladder syndrome 66 ankylosing spondylitis AS 66 Myelodysplastic Syndrome 66 smoldering multiple myeloma 66 malignant ascites 66 imatinib Gleevec 66 homozygous familial hypercholesterolemia 66 dasatinib Sprycel ® 66 pemphigus vulgaris 66 SIR Spheres 66 resectable 66 PEGylated Fab fragment 66 ACZ# 66 stage IIIb 66 atypical Hemolytic Uremic Syndrome 66 superficial bladder cancer 66 small molecule tyrosine 66 generation purine nucleoside 66 recurrent GBM 66 cytoreduction 66 Doxil ® 66 IV metastatic melanoma 66 docetaxel chemotherapy 66 K ras mutations 66 pancreatic neuroendocrine tumors 66 pancreatic carcinoma 66 adriamycin 66 Irinotecan 66 Quinamed 66 allogeneic HSCT 66 refractory AML 65 refractory gout 65 metastatic uveal melanoma 65 lymphoid malignancies 65 systemic fungal infections 65 Glioblastoma multiforme GBM 65 atypical hemolytic uremic syndrome 65 TG# [003] 65 demonstrated antitumor activity 65 psoriatic arthritis PsA 65 non hodgkin lymphoma 65 vinca alkaloid 65 cutaneous T 65 radiation sensitizer 65 non resectable metastatic 65 mitoxantrone plus 65 hA# 65 Allovectin 7 65 Surgical resection 65 ZOLINZA 65 MYCN amplification 65 TYSABRI natalizumab 65 plus gemcitabine 65 relapsing remitting multiple sclerosis 65 Cimzia TM 65 lapatinib Tykerb 65 omega interferon 65 phase IIb trial 65 refractory myeloma 65 squamous cell lung cancer 65 chemotherapy cisplatin 65 cranial radiation 65 haematologic malignancies 65 Neovascular AMD 65 carcinoid 65 AEG# 65 recurrent metastatic 65 metastatic sarcomas 65 Phase #b/#a clinical 65 idiopathic thrombocytopenic purpura ITP 65 pediatric acute lymphoblastic 65 interferon ribavirin 65 Ribavirin causes 65 teriflunomide 65 weekly subcutaneous injections 65 prostate cancer mCRPC 65 Vicinium TM 65 venous stasis ulcers 65 TroVax ® 65 relapsed leukemia 65 5 fluorouracil leucovorin 65 alveolar rhabdomyosarcoma 65 relapsed SCLC 65 MELAS 65 Relapsed Refractory 65 TELINTRA 65 prostate carcinoma 65 Acute Myeloid Leukaemia AML 65 Fingolimod 65 erlotinib Tarceva 65 pertuzumab 65 lenalidomide dexamethasone 65 NMIBC 65 fallopian tube cancers 65 systemic anaplastic large 65 paclitaxel Taxol R 65 standard chemotherapy regimen 65 colorectal carcinoma 65 Akt inhibitor 65 AA amyloidosis 65 lintuzumab SGN 65 OHR/AVR# 65 Enzastaurin 65 oral clodronate 65 elacytarabine 65 standard chemotherapy regimens 65 corticosteroid dexamethasone 65 previously untreated follicular 65 huC# DM4 65 pegylated liposomal doxorubicin 65 neuroendocrine cancers 65 obatoclax 65 LymphoStat B belimumab 65 gemcitabine carboplatin 65 taxane refractory 65 cetuximab Erbitux 65 KRAS wild 65 Vidaza ® 65 chronic myeloid 65 sunitinib malate 65 sunitinib Sutent 65 ELACYT 65 painful diabetic neuropathy 65 Xelox 65 aflibercept VEGF Trap 65 hematologic disorders 65 refractory cutaneous T 65 chronic lymphocytic leukemia CLL 65 Lixivaptan 65 imexon 65 EGFR inhibitors 65 SPRYCEL ® 65 Vandetanib 65 metastatic CRC 65 refractory ovarian cancer 65 refractory metastatic colorectal cancer 65 liposomal amphotericin B 65 nonmetastatic prostate cancer 65 anthracyclines taxanes 65 LEUKINE 65 idarubicin 65 Nexavar sorafenib 65 plus dexamethasone 65 rituximab Rituxan 65 denileukin diftitox 65 YONDELIS 64 diffuse intrinsic pontine glioma 64 PSMA ADC 64 CR# vcMMAE 64 unstable angina UA 64 thymoma 64 heavily pretreated patients 64 investigational monoclonal antibody 64 ribavirin RBV 64 idiopathic pulmonary fibrosis IPF 64 ZYBRESTAT 64 basiliximab 64 IL# PE#QQR 64 metastatic renal cell 64 androgen independent 64 sorafenib Nexavar 64 nonmetastatic 64 esophageal candidiasis 64 Myelofibrosis 64 radiochemotherapy 64 oral picoplatin 64 AGILECT R 64 Allovectin 7 ® 64 Teriflunomide 64 relapsed refractory 64 cetuximab Erbitux R 64 Idiopathic Pulmonary Fibrosis 64 Alocrest 64 phase IIb study 64 DEB# 64 Daclizumab 64 gastrointestinal stromal tumor 64 INCB# [001] 64 retinal vein occlusion induced 64 TNF Tumor Necrosis Factor 64 fluoropyrimidine 64 humanised monoclonal antibody 64 sorafenib tablets 64 capecitabine Xeloda 64 debilitating complication 64 Acute Myelogenous Leukemia AML 64 SCCHN 64 hepatic metastases 64 Aptivus ® 64 microwave hyperthermia 64 INCB# [003] 64 myeloid metaplasia 64 Platinol ® cisplatin 64 gastrointestinal stromal tumors 64 PEG SN# 64 Candida infection 64 Gliadel Wafer 64 FUSILEV enhances 64 EVIZON 64 non splenectomized 64 thetreatment 64 Archexin 64 metastatic RCC 64 ER CHOP 64 Lung transplantation 64 Imprime PGG 64 EOquin TM 64 smoldering myeloma 64 peritoneal cancer 64 novel VDA molecule 64 interferon alfa 2a 64 Epratuzumab 64 Anaplastic 64 CINTREDEKIN BESUDOTOX 64 Combination therapy 64 paclitaxel Taxol ® 64 essential thrombocythemia ET 64 dose escalation phase 64 GOUT 64 PROSTVAC VF 64 transarterial 64 advanced hepatocellular carcinoma 64 TEMODAL 64 bevacizumab Avastin ® 64 trastuzumab Herceptin ® 64 GvHD 64 randomized Phase IIb 64 GISTs 64 paraganglioma 64 ganetespib 64 epithelial tumors 64 unresectable liver cancer 64 metastatic lung cancer 64 FOLFOX6 chemotherapy regimen 64 bendamustine 64 RRMS patients 64 docetaxel Taxotere R 64 Dacogen decitabine 64 chemoresistant 64 taxane chemotherapy 64 benign neoplasms 64 regorafenib 64 symptomatic paroxysmal AF 64 nonsmall cell lung cancer 64 Deforolimus 64 Hsp# Inhibitor 64 CA4P 64 papillary renal cell carcinoma 64 HuLuc# 64 velafermin 64 Basal cell 64 PCNSL 64 intra arterial chemotherapy 64 complement inhibitor eculizumab 64 benign prostatic hypertrophy BPH 64 galiximab 64 visceral metastases 64 ALA PDT 64 Multiple Myeloma MM 64 alkylating agent 64 refractory colorectal cancer 64 CLL SLL 64 sorafenib Nexavar ® 64 ribavirin Copegus ® 64 MGd 64 Panzem R NCD 64 TORISEL 64 diagnosed glioblastoma multiforme 64 MAGE A3 ASCI 64 Xeloda capecitabine 64 Hormone Refractory Prostate Cancer 64 ANCA associated 64 neoadjuvant treatment 64 Telintra 64 abacavir Ziagen 64 Annamycin 64 arthritis PsA 64 rALLy clinical trial 64 adalimumab Humira 64 Naive Patients 64 Adjuvant chemotherapy 64 indolent follicular non 64 lymphocytic leukemia 64 neratinib 64 pheochromocytoma 64 Amplimexon 64 platelet inhibitor 64 resectable pancreatic cancer 64 lomitapide 64 antiangiogenic agent 64 myelodysplastic syndrome MDS 64 Cimzia ® certolizumab pegol 64 Glioblastoma multiforme 64 anticancer therapy 64 Cell Lymphoma 64 Virulizin ® 64 skeletal metastases 64 medullary thyroid cancer 64 Bayer HealthCare Onyx Pharmaceuticals 64 osteoporotic compression fractures 64 overt nephropathy 64 inoperable pancreatic cancer 64 candidemia 64 SNT-MC#/idebenone 64 thyrotoxicosis 64 Phase Ib clinical 64 Cloretazine 64 hepatic encephalopathy HE 64 MYCAMINE 64 HeFH 64 GW# [003] 64 refractory acute myeloid 64 eosinophilic asthma 64 entinostat 64 Pseudomonas aeruginosa infections 64 AA Amyloidosis 64 infective endocarditis 64 PNP inhibitor 64 Acute myeloid leukemia AML 64 mCRPC 64 ADPKD 64 chemoradiation therapy 64 Bronchiectasis 64 acetonide FA 64 FOLFOX4 64 potentially hepatotoxic 64 Genasense ® 63 MKC# MT 63 chronic myocardial ischemia 63 romidepsin 63 cancer mCRC 63 GIST tumors 63 BrachySil TM 63 CIMZIA TM 63 Gemzar ® 63 Alessandro Riva 63 acute leukemias 63 taxane resistant 63 decitabine 63 mCRC patients 63 osteosarcoma rare 63 DU #b 63 IV melanoma 63 opioid induced constipation OIC 63 refractory multiple myeloma 63 Chronic myeloid leukemia 63 Cutaneous T 63 cangrelor 63 Omacetaxine 63 Bezielle 63 MYDICAR 63 LBH# 63 paclitaxel poliglumex 63 oxaliplatin Eloxatin 63 primary immunodeficiency PI 63 XL# SAR# 63 dexrazoxane 63 CTEPH 63 gemcitabine Gemzar 63 alfa 2a 63 chronic thromboembolic pulmonary 63 BRAF inhibitor 63 hepatorenal syndrome 63 octreotide implant 63 MALT lymphoma 63 chemoradiotherapy 63 differentiated thyroid 63 rhabdoid 63 Philadelphia Chromosome Positive 63 medically inoperable 63 choroidal vasculopathy 63 IMA# 63 cinacalcet 63 Plicera 63 receiving VELCADE 63 HGS# 63 Tarceva TM 63 docetaxel prednisone 63 mertansine 63 oblimersen 63 sargramostim 63 ibandronate 63 volociximab 63 gemcitabine chemotherapy 63 Mipomersen 63 Natalizumab 63 maximally tolerated lipid lowering 63 antimetabolite 63 HER2 positive cancers 63 Tyrima 63 ABVD 63 BR.# 63 cyclophosphamide chemotherapy 63 bardoxolone methyl 63 ovarian carcinoma 63 imatinib resistant 63 pouchitis 63 therapeutic regimens 63 acute myelogenous leukemia AML 63 antiangiogenesis therapies 63 Gliomas 63 pomalidomide 63 Uricase PEG 63 vinorelbine 63 Certolizumab pegol 63 Fludarabine 63 myelodysplastic myeloproliferative diseases 63 Campath alemtuzumab 63 radiotherapy RT 63 idiopathic thrombocytopenic purpura 63 completely resected 63 C1 INH deficiency 63 mTOR inhibitors 63 basal bolus regimen 63 Rituxan rituximab 63 ATL/TV# 63 MYDICAR ® 63 Mitoxantrone 63 HuMax CD4 63 DAPT 63 acute lymphoblastic 63 grade cervical intraepithelial 63 lenalidomide Revlimid R 63 familial hypercholesterolemia FH 63 lymphomas leukemias 63 pamidronate 63 Chronic lymphocytic leukemia CLL 63 immune thrombocytopenic purpura ITP 63 neurological manifestations 63 Capesaris 63 Hodgkin lymphoma HL 63 myeloproliferative disorders 63 acute GvHD 63 reslizumab 63 mycosis fungoides 63 tumor lysis syndrome 63 biologic DMARD 63 Phase IIIb clinical 63 stage IIIA 63 sJIA 63 membranous nephropathy 63 TO AVOID PREGNANCY WHILE 63 Mitral valve repair 63 alemtuzumab Campath 63 hormone refractory 63 infusional 63 Phase Ib II 63 mycophenolate mofetil 63 liposomal doxorubicin 63 pancreatic prostate 63 cyclophosphamide FC 63 sunitinib Sutent ® 63 Pegasys plus Copegus 63 hepatocellular carcinoma HCC 63 follicular lymphomas 63 Velcade bortezomib 63 calcineurin inhibitor 63 NSCL cancer 63 antiretroviral naïve 63 Acute Coronary Syndromes ACS 63 schizophrenia CIAS 63 ErbB2 positive 63 nilotinib Tasigna 63 biotherapy 63 pulmonary hypertension PH 63 hyperphenylalaninemia HPA due 63 recurrent glioma 63 VAPRISOL 63 Platinol ® 63 clevidipine 63 ATTR PN 63 tyrosine kinase inhibitors TKIs 63 INTEGRILIN R 63 oral deforolimus 63 Inhaled nitric oxide 63 surgical debulking 63 metastatic renal 63 radiation chemoradiation 63 interferon beta therapy 63 ulimorelin 63 cervical lymph nodes 63 paclitaxel carboplatin 63 alefacept 63 steroid refractory ulcerative 63 BRCA deficient 63 aerosolized KL4 surfactant 63 rindopepimut 63 cholangiocarcinoma 63 LHON 63 liver resection 63 ulcerative colitis UC 63 Pegylated Interferon 63 leiomyosarcoma 63 Degarelix 63 ZD# [001] 63 ospemifene 63 Sapacitabine 63 malignant pleural mesothelioma 63 Sudhir Agrawal D.Phil 63 functional mitral regurgitation 63 Navelbine ® 63 certolizumab 63 PEG interferon 63 AKT inhibitor 63 TLK# 63 Anti VEGF 63 anterior uveitis 63 thrombocytopenic patients 63 null responder HCV 63 IRX 2 63 Torisel 63 OncoVEX GM CSF 63 platinum refractory 63 KRAS mutations occur 63 proliferative retinopathy 63 unresectable 63 Factor VIIa 63 dirucotide MBP# 63 aHUS 63 R Saizen R 63 locoregional disease 63 malignant pancreatic 63 occlusion PAO 63 #I TM# 63 trastuzumab Herceptin R 63 RAS mutations 63 bleomycin 63 Temodar ® 63 hypereosinophilic syndrome 63 chronic HCV 63 gamma secretase inhibitor 63 acute myeloid 63 Genz # 63 Peginterferon alfa 2b 63 Papillary 63 Atypical Hemolytic Uremic Syndrome 63 autoantibody positive 63 Pharmacokinetics PK 63 selective modulator 63 docetaxel Taxotere 63 stage IIIb IV 63 liver metastases 63 Darusentan 63 treatment naïve genotype 63 Paroxysmal Nocturnal Hemoglobinuria PNH 63 curative resection 63 huN# DM1 63 EGFR TKI 63 uterine fibroid 63 ponatinib 63 JAK2 inhibitor 63 bone metastasis 63 allogeneic bone marrow 63 Amrubicin 63 neovascular 63 dacarbazine DTIC 63 relapsed AML 63 homozygous FH 63 hypercalcemia 63 malignant lymphomas 62 beta 1a 62 oral rivaroxaban 62 cardiotoxic 62 ThermoDox R 62 hereditary deficiency 62 Gleevec imatinib mesylate 62 HGS ETR1 mapatumumab 62 chronic myelogenous leukemia CML 62 pan HDAC inhibitor 62 Phase #b/#a trial 62 PsA 62 renal tumors 62 TBC# 62 TKI therapy 62 Elotuzumab 62 PEG IFN 62 esophagogastric 62 situ CIS 62 cortical stimulation 62 nonalcoholic steatohepatitis NASH 62 TNF antagonist 62 gastrointestinal toxicities 62 Personalized Immunotherapy 62 Smac mimetics 62 rheumatoid arthritis RA psoriatic 62 TNF alpha antagonist 62 trabedersen 62 hypercholesterolemic patients 62 Phase Ib study 62 IFN beta 62 8mg/kg 62 severe malignant osteopetrosis 62 arterial thrombosis 62 transthyretin amyloidosis 62 isoform selective 62 ProSavin 62 thrombocytopenic 62 HCD# [002] 62 basal cell cancers 62 Albuferon TM 62 Safinamide 62 tuberous sclerosis TS 62 satraplatin Phase 62 hormone refractory metastatic prostate 62 urothelial cancer 62 OMNARIS HFA 62 seminoma 62 bevacizumab Avastin R 62 Glioma 62 carboplatin paclitaxel 62 precancerous condition 62 either acutely decompensated 62 Severe Primary IGFD 62 crizotinib PF # 62 TTR amyloidosis 62 Interferon beta 62 virus HCV infection 62 BRAF inhibitors 62 glufosfamide 62 baminercept 62 endocrine therapies 62 Vaprisol 62 PXD# 62 Brentuximab Vedotin SGN 62 motesanib 62 secondary hyperparathyroidism 62 SUPPRELIN R LA 62 Dasatinib 62 carcinoma HCC 62 acyclovir Lauriad R 62 induce remission 62 Folfox 62 acute promyelocytic leukemia 62 PEGylated interferon 62 PI3K/Akt pathway inhibitor 62 transplantation HCT 62 haematologic 62 olaparib 62 prostate carcinomas 62 PROCHYMAL 62 ixabepilone 62 evaluating Prochymal 62 DCVax ® Brain 62 refractory angina 62 Tavocept 62 SNT MC# 62 post herpetic neuralgia 62 receiving immunosuppressive therapy 62 VEGF inhibitors 62 follicular lymphoma FL 62 paclitaxel Taxol 62 anticancer compound 62 miglustat 62 Romidepsin 62 pulmonary metastasis 62 adecatumumab 62 PEGINTRON TM 62 ancrod 62 VEGFR2 inhibitor 62 TAXOTERE ® 62 chronic eosinophilic leukemia 62 DCVax R 62 placebo controlled clinical 62 Gleevec imatinib 62 astrocytomas 62 Heterozygous Familial Hypercholesterolemia 62 mapatumumab 62 castration resistant 62 paroxysmal atrial fibrillation 62 intraventricular 62 mTOR inhibitor 62 Eculizumab 62 zalutumumab 62 post thrombotic syndrome 62 castrate resistant 62 dirucotide 62 null responder 62 Seliciclib 62 orally administered inhibitor 62 canagliflozin 62 metastatic kidney 62 atrial tachyarrhythmias 62 targeted radiotherapeutic 62 Kepivance 62 aldosterone antagonists 62 hematological malignancy 62 relapsing remitting 62 elotuzumab 62 receptor inhibitor 62 Aggrastat ® tirofiban hydrochloride 62 colorectal adenocarcinoma 62 rFVIIa 62 lymphoma CTCL 62 TACI Ig 62 BRAF V#E mutation 62 BCR ABL inhibitors 62 rheumatoid arthritis psoriatic arthritis 62 cytopenias 62 medically refractory 62 etanercept Enbrel 62 Flu Cy 62 Cetuximab Erbitux 62 essential thrombocythemia 62 TNF blocker therapy 62 lung pancreatic 62 Refractory Hodgkin Lymphoma 62 refractory chronic myeloid 62 myeloproliferative disorder 62 Diabetic Macular Edema DME 62 VA# [002] 62 Abrupt discontinuation 62 Relapsing remitting MS 62 solid tumors 62 mTOR inhibition 62 Kit CD# positive 62 luteinizing hormone releasing 62 5-fluorouracil/leucovorin 62 Laquinimod 62 polycythemia vera essential thrombocythemia 62 vandetanib 62 remission induction 62 anti angiogenic agent 62 BENLYSTA ® 62 anthracycline taxane 62 Metastatic Melanoma 62 Ozarelix 62 LE DT 62 refractory prostate cancer 62 phase IIa clinical 62 AQ4N 62 temozolomide Temodar 62 somatostatin analog 62 canakinumab 62 pain palliation 62 oral methylnaltrexone 62 Leber Hereditary Optic Neuropathy 62 budesonide foam 62 farletuzumab 62 MP4OX 62 relapsed CLL 62 occlusive disease 62 Cell Lymphoma CTCL 62 ximelagatran 62 metastatic adenocarcinoma 62 Angioedema 62 hoFH 62 invasive lobular carcinoma 62 Insegia 62 advanced carcinoid 62 including eniluracil ADH 62 gastric carcinoma 62 renal carcinoma 62 autologous transplants 62 Vitaxin 62 recurrent malignant gliomas 62 Hodgkin lymphoma NHL 62 Fludara ® 62 Crohn disease CD 62 terlipressin 62 steroid refractory 62 PKC# 62 Waldenstrom macroglobulinemia 62 pancreatic islet cell 62 Troxatyl 62 salmeterol fluticasone 62 acute peripheral arterial 62 azacytidine 62 MEK inhibitor RDEA# 62 pegylated interferon alfa 2a 62 plasminogen activators 62 Tamibarotene 62 carcinoid syndrome 62 oropharyngeal candidiasis OPC 62 familial amyloidotic polyneuropathy FAP 62 steroid refractory GvHD 62 IV malignant melanoma 62 AVASTIN 62 zanolimumab 62 superficial basal cell carcinoma 62 Chronic pancreatitis 62 trastuzumab DM1 T DM1 62 PREZISTA r 62 Imatinib mesylate 62 Etanercept 62 Oral corticosteroids 62 ovarian suppression 62 leukemia CML 62 CCR9 antagonist 62 Malignant Glioma 62 thymic carcinoma 62 gastric cancers 62 metastatic colon cancer 62 geographic atrophy 62 aortic valve stenosis 62 alpha1 antitrypsin deficiency 62 noninfectious uveitis 62 primary hyperparathyroidism 62 chemotherapy docetaxel 62 taxane therapy 62 active ankylosing spondylitis 62 dose cohort 62 dopaminergic therapy 62 SERCA2a 62 icatibant 62 antiarrhythmic drug 62 osteosarcomas 62 metastatic melanoma 62 leukaemias 62 Triapine 62 LHRH analogues 62 Thal Dex 62 antithrombotic therapy 62 Hypotension 62 NAVISTAR R 62 MMP inhibitors 62 glioblastoma tumors 62 amrubicin 62 pulmonary metastases 62 diabetic kidney 62 Decitabine 62 oral FTY# 62 toenail onychomycosis 62 Combination REOLYSIN R 62 ® lenalidomide 62 Stage IIB 62 cannabinor 62 pegylated interferon alfa 62 minimally symptomatic 62 intravesical therapy 62 glioblastoma GBM 62 papillary thyroid carcinoma 62 Lupus Nephritis 62 opioid induced bowel dysfunction 62 Lisofylline 62 hematologic toxicity 62 CD# CEA 62 vaccines oncolytic virus 62 Neovascular Age Related Macular 62 colon carcinoma 62 GAMMAGARD 62 HCV SPRINT 62 nilotinib Tasigna ® 62 Chronic Myelogenous Leukemia CML 62 dimensional conformal radiation 62 mutated KRAS 62 adenomatous